Tower Research Capital (TRC)’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$133K Buy
4,137
+3,014
+268% +$111K ﹤0.01% 1956
2025
Q4
$43.1K Sell
1,123
-449
-29% -$9.85K ﹤0.01% 2537
2025
Q3
$21.6K Sell
1,572
-4,594
-75% -$53.9K ﹤0.01% 3249
2025
Q2
$79.7K Buy
6,166
+4,581
+289% +$47.6K ﹤0.01% 2566
2025
Q1
$17.8K Buy
1,585
+364
+30% +$4.78K ﹤0.01% 3088
2024
Q4
$16K Buy
1,221
+1,077
+748% +$27.6K ﹤0.01% 3373
2024
Q3
$5.76K Buy
+144
New +$5.24K ﹤0.01% 4226

Other funds holding PACS

Tower Research Capital (TRC)'s PACS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its PACS Group (PACS) stake by 268% in Q1 2026, buying an estimated $111K and bringing the position to 4,137 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Tower Research Capital (TRC) first reported a position in PACS in Q3 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Tower Research Capital (TRC) held 4,137 shares of PACS Group worth $133K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,014 PACS Group shares in Q1 2026, an estimated $111K.
  • PACS Group made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1956 holding.
  • Tower Research Capital (TRC) first reported a position in PACS Group in Q3 2024 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.